EP 0809511 A1 19971203 - INHIBITION OF ANGIOGENESIS USING INTERLEUKIN-12
Title (en)
INHIBITION OF ANGIOGENESIS USING INTERLEUKIN-12
Title (de)
HEMMUNG DER ANGIOGENESE MITTELS INTERLEUKIN-12
Title (fr)
INHIBITION DE L'ANGIOGENESE A L'AIDE DE L'INTERLEUKINE-12
Publication
Application
Priority
- EP 9600507 W 19960207
- US 38938295 A 19950216
Abstract (en)
[origin: WO9625171A1] The present invention relates to the use of Interleukin-12 for the preparation of a medicament for the treatment of undesired or uncontrolled angiogenesis, which is important in the treatment of diabetic retinopathy and macular degeneration.
IPC 1-7
IPC 8 full level
A61K 38/00 (2006.01); A61K 38/20 (2006.01); A61P 3/08 (2006.01); A61P 3/10 (2006.01); A61P 9/00 (2006.01); A61P 17/00 (2006.01); A61P 27/02 (2006.01); A61P 29/00 (2006.01); A61P 31/04 (2006.01); A61P 31/12 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP)
A61K 38/208 (2013.01); A61P 3/08 (2017.12); A61P 3/10 (2017.12); A61P 9/00 (2017.12); A61P 17/00 (2017.12); A61P 27/02 (2017.12); A61P 29/00 (2017.12); A61P 31/04 (2017.12); A61P 31/12 (2017.12); A61P 35/00 (2017.12)
Citation (search report)
See references of WO 9625171A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9625171 A1 19960822; AU 4788396 A 19960904; BR 9607427 A 19980623; CA 2212370 A1 19960822; EP 0809511 A1 19971203; FI 973356 A0 19970815; FI 973356 A 19970815; JP H11500119 A 19990106; MX 9706188 A 19971129; TR 199700801 T1 19980321
DOCDB simple family (application)
EP 9600507 W 19960207; AU 4788396 A 19960207; BR 9607427 A 19960207; CA 2212370 A 19960207; EP 96904008 A 19960207; FI 973356 A 19970815; JP 52463196 A 19960207; MX 9706188 A 19960207; TR 9700801 T 19960207